Clover Health Investments (CLOV) Shares Outstanding (2019 - 2026)

Clover Health Investments (CLOV) has 8 years of Shares Outstanding (Entity) data on file, last reported at $429.6 million in Q1 2026.

• Quarterly Shares Outstanding (Entity) rose 3.72% year-over-year to $429.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $429.6 million (up 3.72% YoY) and the FY2025 annual result came in at $426.7 million, up 2.94% from the prior year.
• Shares Outstanding (Entity) climbed to $429.6 million in Q1 2026, from $426.7 million in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $567.5 million in Q1 2024 to a low of $383.5 million in Q3 2022.
• A 5-year average of $424.6 million and a median of $414.2 million in 2025 frame the typical range for Shares Outstanding (Entity).
• Annual changes were most pronounced in 2024 — Shares Outstanding (Entity) soared 43.98% — and 2025, when it dropped 27.01%.
• Tracing CLOV's Shares Outstanding (Entity) over 5 years: stood at $384.0 million in 2022, then climbed by 4.48% to $401.2 million in 2023, then increased by 3.32% to $414.5 million in 2024, then grew by 2.94% to $426.7 million in 2025, then climbed by 0.68% to $429.6 million in 2026.
• The last three Shares Outstanding (Entity) figures came in at $429.6 million (Q1 2026), $426.7 million (Q4 2025), and $421.8 million (Q3 2025), per Business Quant data.